Analysis of the Role of Hepatocyte SLAMF3 Receptor and Drug Resistance Proteins (MDR) in Resistance to Treatment With Sorafenib in CHC Patients
Clinical trial NCT03113604 · WITHDRAWN
Trial details
- NCT number
- NCT03113604
- Sponsor
- Centre Hospitalier Universitaire, Amiens
- Status
- WITHDRAWN
- Study type
- OBSERVATIONAL
- Start date
- 2015-11-20
- Primary completion
- 2016-11-20
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.